NPIPB2: A Drug Target and Biomarker for Nuclear Pore Complex Interacting Protein Family Member B2
NPIPB2: A Drug Target and Biomarker for Nuclear Pore Complex Interacting Protein Family Member B2
Unlocking the Potential of NPIPB2: A Promising Drug Target and Biomarker for Nuclear Pore Complex Interacting Protein Family Member B2
Introduction
Nuclear pore complex (NPC) is a protein-protein interaction network that plays a crucial role in the regulation of gene expression, DNA replication, and repair, and cell signaling pathways. Nuclear pore complex interacting protein family member B2 (NPIPB2) is a key protein that functions as a negative regulator of the NPC, thereby influencing various cellular processes. NPIPB2 has been identified as a potential drug target and biomarker due to its unique structure, subcellular localization, and involvement in multiple cellular processes.
Structure and Subcellular Localization of NPIPB2
NPIPB2 is a 21-kDa protein that contains 115 amino acid residues. It has a unique 2-dimensional structure, with a long N-terminal region that includes a transmembrane domain and a cytoplasmic tail. The N-terminal region is rich in conserved amino acids , such as alanine, aspartic acid, and glutamic acid, which are crucial for protein stability and function.
The cytoplasmic tail of NPIPB2 is characterized by a unique farnesylated cysteine 鈥嬧?媟esidue, which is a hallmark of NPC-interacting proteins. This cysteine 鈥嬧?媟esidue is involved in the formation of the NPC and plays a critical role in regulating the NPC's stability and functions.
Function and Druggability of NPIPB2
NPIPB2's unique 2-dimensional structure and its involvement in various cellular processes make it an attractive drug target and biomarker. The NPC is a protein-protein interaction network that plays a crucial role in regulating gene expression, DNA replication, and repair, and cell signaling pathways. NPIPB2 is a negative regulator of the NPC, which means that it promotes the assembly and stability of NPCs, and inhibits their disassembly.
The NPC is composed of multiple subunits that have different functions, such as the nuclear export machine (NEM), the nuclear import machine (NIM), and the DNA replication machinery. NPIPB2 is specifically involved in the NPC's function as a negative regulator of the NIM, which is responsible for importing and exporting nuclear proteins.
The drug targeting of NPIPB2 involves modulating its stability and functions to disrupt the NPC's regulation of gene expression and cellular processes. Various chemical modifications, such as pharmacological agents and small molecules, have been shown to interact with NPIPB2 and modulate its stability and functions. For For example, small molecules that can inhibit the NIM have been shown to decrease NPC assembly and stability, leading to reduced gene expression and cellular processes.
As a potential biomarker, NPIPB2 can be used to diagnose and monitor various diseases, including cancer, neurodegenerative diseases, and chronic diseases. For example, increased NPC assembly and stability have been observed in various cancer cells, which may contribute to their enhanced malignant properties. . Similarly, decreased NPC assembly and stability have been observed in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, which may contribute to the loss of cellular processes and protein synthesis.
Conclusion
In conclusion, NPIPB2 is a unique and promising protein that functions as a negative regulator of the NPC. Its 2-dimensional structure and its involvement in various cellular processes make it an attractive drug target and biomarker. The study of NPIPB2's function and druggability has significant implications for the development of new treatments for various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Further research is needed to fully understand the role of NPIPB2 in cellular processes and its potential as a drug target and biomarker.
Protein Name: Nuclear Pore Complex Interacting Protein Family Member B2
The "NPIPB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPIPB2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NPIPB3 | NPIPB4 | NPIPB5 | NPIPB7 | NPIPB8 | NPIPB9 | NPIPP1 | NPL | NPLOC4 | NPM1 | NPM1P13 | NPM1P21 | NPM1P22 | NPM1P25 | NPM1P27 | NPM1P28 | NPM1P35 | NPM1P42 | NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2
